Insmed
INSM
#752
Rank
NZ$56.67 B
Marketcap
NZ$258.35
Share price
-2.17%
Change (1 day)
-27.01%
Change (1 year)

Earnings for Insmed (INSM)

Earnings in 2026 (TTM): -NZ$0.91 Billion

According to Insmed's latest financial reports the company's current earnings are NZ$1.51 Billion. In 2025 the company made an earning of -NZ$2.19 Billion a decrease over its 2024 earnings that were of -NZ$1.52 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insmed from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.91 Billion-58.45%
2025 -NZ$2.19 Billion43.91%
2024 -NZ$1.52 Billion23.71%
2023 -NZ$1.23 Billion45.77%
2022 -NZ$0.85 Billion15.83%
2021 -NZ$0.73 Billion50.19%
2020 -NZ$0.49 Billion16.4%
2019 -NZ$0.42 Billion-23.9%
2018 -NZ$0.55 Billion59.35%
2017 -NZ$0.35 Billion8.52%
2016 -NZ$0.32 Billion47.25%
2015 -NZ$0.22 Billion34.53%
2014 -NZ$0.16 Billion58.83%
2013 -NZ$0.11 Billion35.14%
2012 -NZ$74.24 Million-31.92%
2011 -NZ$0.11 Billion854.92%
2010 -NZ$11.42 Million-105.22%
2009 NZ$0.21 B-905.06%
2008 -NZ$27.16 Million-27.31%
2007 -NZ$37.37 Million-62.41%
2006 -NZ$99.4 Million98.19%
2005 -NZ$50.15 Million0.03%
2004 -NZ$50.14 Million159.07%
2003 -NZ$19.36 Million-69.31%
2002 -NZ$63.05 Million
2000 -NZ$56.85 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
NZ$23.11 B-2,520.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
-NZ$4.64 Billion 384.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$8.33 B-973.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-NZ$0.24 Billion-74.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-NZ$42.49 Million-95.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
-NZ$94.42 Million-90.11%๐Ÿ‡บ๐Ÿ‡ธ USA